William P. Forbes, EVP, Chief Development Officer at HERON THERAPEUTICS, INC. /DE/ (HRTX), bought 25,000 shares at $1.09 ($27K) on 2023-11-17, disclosed to the SEC on 2023-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| XAIR | BUY | 2023-03-20 | $32K | — | Filing → |
| XAIR | BUY | 2019-11-15 | $25K | — | Filing → |
| SLXP | SELL | 2015-03-11 | $6.8M | — | Filing → |